Michael Barbella, Managing Editor06.03.23
News about new matters—products, data, and websites—drove the bulk of ODT website traffic this past post-holiday week.
THINK Surgical led the charge with the FDA 510(k) clearance of its TMINI miniature robotic system, which features a wireless robotic handpiece to assist with total knee replacement. The handpiece follows a CT-based, 3D surgical plan to automatically compensate for surgeon hand movement to locate bone pins along precisely defined planes. Cutting guides are then connected to the bone pins to accurately resect bone. THINK Surgical intends to use an open implant library and add new implant options over time.
Exactech marked the latest release of its ExactechGPS navigation software with more than 200 surgeons at the company's annual Shoulders Masters Course in Amsterdam. Exactech plans to launch the updated software to surgeons in the EMEA and APAC regions after this operation. The U.S. launch of v2.2 has a new web upload feature that allows healthcare professionals to upload shoulder CT scans for reconstruction through the web.
Arthrex, meanwhile, garnered pageviews by launching a new patient-focused website that illustrates the science of anterior cruciate ligament (ACL) injuries, highlights the benefits of knee preservation technology and provides tools to patients to connect with surgeons performing advanced, minimally invasive ACL procedures. ACLTear.com offers an interactive Find a Doctor tool to help patients quickly and easily connect with surgeons in their area.
Moximed also attracted cybervisitors by releasing encouraging supporting data for the Moximed’s MISHA Knee System, an implantable shock absorber (ISA) for patients with osteoarthritis (OA) who are not ready for a knee replacement. Data from three clinical studies show that implantation of the ISA in symptomatic patients with knee OA resulted in a five-year freedom from arthroplasty rate of 85%. The results from the most recent study, which featured the commercially available MISHA Knee System and most advanced surgical instruments, showed the greatest survival rate, with a median three-year rate of over 97%. Simultaneously, a cohort of patients from the Calypso Study of the MISHA Knee System with subchondral insufficiency fractures of the knee (SIFK) demonstrated a reduced risk of conversion to arthroplasty when treated with the ISA compared to a matched cohort of non-surgically treated patients.
THINK Surgical led the charge with the FDA 510(k) clearance of its TMINI miniature robotic system, which features a wireless robotic handpiece to assist with total knee replacement. The handpiece follows a CT-based, 3D surgical plan to automatically compensate for surgeon hand movement to locate bone pins along precisely defined planes. Cutting guides are then connected to the bone pins to accurately resect bone. THINK Surgical intends to use an open implant library and add new implant options over time.
Exactech marked the latest release of its ExactechGPS navigation software with more than 200 surgeons at the company's annual Shoulders Masters Course in Amsterdam. Exactech plans to launch the updated software to surgeons in the EMEA and APAC regions after this operation. The U.S. launch of v2.2 has a new web upload feature that allows healthcare professionals to upload shoulder CT scans for reconstruction through the web.
Arthrex, meanwhile, garnered pageviews by launching a new patient-focused website that illustrates the science of anterior cruciate ligament (ACL) injuries, highlights the benefits of knee preservation technology and provides tools to patients to connect with surgeons performing advanced, minimally invasive ACL procedures. ACLTear.com offers an interactive Find a Doctor tool to help patients quickly and easily connect with surgeons in their area.
Moximed also attracted cybervisitors by releasing encouraging supporting data for the Moximed’s MISHA Knee System, an implantable shock absorber (ISA) for patients with osteoarthritis (OA) who are not ready for a knee replacement. Data from three clinical studies show that implantation of the ISA in symptomatic patients with knee OA resulted in a five-year freedom from arthroplasty rate of 85%. The results from the most recent study, which featured the commercially available MISHA Knee System and most advanced surgical instruments, showed the greatest survival rate, with a median three-year rate of over 97%. Simultaneously, a cohort of patients from the Calypso Study of the MISHA Knee System with subchondral insufficiency fractures of the knee (SIFK) demonstrated a reduced risk of conversion to arthroplasty when treated with the ISA compared to a matched cohort of non-surgically treated patients.